Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marie-Paule Roman"'
Autor:
Patrick Van Dreden, Jean François Bernaudin, Elisabeth Mbemba, Mouna Sassi, Max Japcowitz, Grigoris T. Gerotziafas, Jawed Fareed, Mohamed Hatmi, Jean Pierre Lotz, Amir Khaterchi, Vassiliki Galea, Marie-Paule Roman, Ismail Elalamy
Publikováno v:
Current Vascular Pharmacology. 12:893-902
Low molecular weight heparins (LMWHs) and fondaparinux are widely used for prophylaxis and treatment of venous thromboembolic disease in cancer patients. However, the optimization of the antithrombotic treatment especially in patients with adenocarci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b081be5cb3998361874bda0865f0e68
https://doi.org/10.2174/157016111206141210121441
https://doi.org/10.2174/157016111206141210121441
Autor:
Dimitra Karipidi, Vassiliki Galea, Ismail Elalamy, Patrick Van Dreden, Ilias Evmorfiadis, Grigoris T. Gerotziafas, Severin Bouffard, Amir Kartechi, Marie-Paule Roman
Publikováno v:
Blood. 122:3631-3631
Background Clopidogrel is cornerstone treatment for atherothrombotic patients. The incidence of recurrent thrombotic events raises up to 10% of patients on treatment with clopidogrel. Intestinal absorption via the glycoproteine ABCB1, bioactivation b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f74665ebb32e35f8cd49eeebb5482987
https://doi.org/10.1182/blood.v122.21.3631.3631
https://doi.org/10.1182/blood.v122.21.3631.3631
Autor:
Ismail Elalamy, Elisabeth Verdy, Grigoris T. Gerotziafas, Marie-Paule Roman, Jean-François Bernaudin, Claudine Prengel
Publikováno v:
Blood. 110:3992-3992
Tissue factor (TF) expressed by some cancer cells is implicated in metastasis and angiogenesis. The influence of cancer cells on blood coagulation has not been adequately studied. We evaluated the procoagulant potential of pancreatic and breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d612263e4001c1bd9ef1b5284b532cbe
https://doi.org/10.1182/blood.v110.11.3992.3992
https://doi.org/10.1182/blood.v110.11.3992.3992
Autor:
Marie-Paule Roman, Mohamed Hatmi, Elisabeth Verdy, Grigoris T. Gerotziafas, Meyer Michel Samama, Ismail Elalamy
Publikováno v:
Blood. 110:929-929
Argatroban is a synthetic, reversible, direct thrombin inhibitor (DTI) used in patients with heparin induced thrombocytopenia (HIT). Argatroban as other DTIs prolongs PT, aPTT and ecarin clotting time. Argatroban added in vitro in normal platelet poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::484029112ec33847582245348275612b
https://doi.org/10.1182/blood.v110.11.929.929
https://doi.org/10.1182/blood.v110.11.929.929